$2.41
0.020.84%
At Close: -
$2.41
00.00%
After Hours: 5:08 PM EDT
15 minutes delayed
Esperion Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Esperion Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ESPR | Esperion Therapeutics | -$0.46 | -$0.15 | — | — | $25.79M | $50.59M | — | — | 08/02/2024 | Get Alert |
ESPR | Esperion Therapeutics | -$0.79 | $0.05 | $0.34 | 580.00% | $24.33M | $84.51M | $137.74M | 62.98% | 05/07/2024 | Get Alert |
ESPR | Esperion Therapeutics | -$0.76 | -$0.48 | -$0.50 | -4.17% | $18.82M | $28.70M | $32.25M | 12.37% | 02/27/2024 | Get Alert |
ESPR | Esperion Therapeutics | -$0.81 | -$0.43 | -$0.37 | 13.95% | $18.98M | $29.58M | $33.97M | 14.84% | 11/07/2023 | Get Alert |
ESPR | Esperion Therapeutics | -$1.05 | -$0.63 | -$0.46 | 26.98% | $18.84M | $25.50M | $25.79M | 1.12% | 08/01/2023 | Get Alert |
ESPR | Esperion Therapeutics | -$0.93 | -$0.65 | -$0.79 | -21.54% | $18.84M | $22.01M | $24.33M | 10.54% | 05/09/2023 | Get Alert |
ESPR | Esperion Therapeutics | -$1.77 | -$0.84 | -$0.76 | 9.52% | $15.40M | $20.85M | $18.82M | -9.75% | 02/21/2023 | Get Alert |
ESPR | Esperion Therapeutics | -$2.62 | -$0.93 | -$0.81 | 12.90% | $14.41M | $19.74M | $18.98M | -3.85% | 11/01/2022 | Get Alert |
ESPR | Esperion Therapeutics | -$1.67 | -$0.93 | -$1.05 | -12.90% | $40.66M | $18.71M | $18.84M | 0.70% | 08/02/2022 | Get Alert |
ESPR | Esperion Therapeutics | -$3.50 | -$1.04 | -$0.93 | 10.58% | $7.98M | $15.39M | $18.84M | 22.39% | 05/03/2022 | Get Alert |
ESPR | Esperion Therapeutics | -$3.89 | -$2.27 | -$1.77 | 22.03% | $9.64M | $14.47M | $15.40M | 6.43% | 02/22/2022 | Get Alert |
ESPR | Esperion Therapeutics | -$3.07 | -$2.79 | -$2.62 | 6.09% | $3.83M | $12.85M | $14.41M | 12.13% | 11/02/2021 | Get Alert |
ESPR | Esperion Therapeutics | $4.32 | -$1.84 | -$1.67 | 9.24% | $212.24M | $42.27M | $40.66M | -3.81% | 08/03/2021 | Get Alert |
ESPR | Esperion Therapeutics | -$2.84 | -$2.52 | -$3.50 | -38.89% | $1.84M | $26.12M | $7.98M | -69.46% | 05/04/2021 | Get Alert |
ESPR | Esperion Therapeutics | -$2.26 | -$3.76 | -$3.89 | -3.46% | $982.00K | $12.52M | $9.64M | -23.02% | 02/23/2021 | Get Alert |
ESPR | Esperion Therapeutics | -$2.52 | -$3.41 | -$3.07 | 9.97% | $981.00K | $5.93M | $3.83M | -35.36% | 11/02/2020 | Get Alert |
ESPR | Esperion Therapeutics | -$2.01 | $1.71 | $4.32 | 152.63% | $982.00K | $147.97M | $212.24M | 43.43% | 08/10/2020 | Get Alert |
ESPR | Esperion Therapeutics | $3.07 | -$3.29 | -$2.84 | 13.68% | $145.42M | $520.00K | $1.84M | 253.85% | 05/06/2020 | Get Alert |
ESPR | Esperion Therapeutics | -$2.24 | -$2.67 | -$2.26 | 15.36% | $0.00 | — | $982.00K | — | 02/27/2020 | Get Alert |
ESPR | Esperion Therapeutics | -$1.86 | -$1.95 | -$2.52 | -29.23% | $0.00 | $900.00K | $981.00K | 9.00% | 11/06/2019 | Get Alert |
ESPR | Esperion Therapeutics | -$1.71 | -$1.86 | -$2.01 | -8.06% | $0.00 | $930.00K | $982.00K | 5.59% | 08/08/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-07 | $0.34 | $0.05 | 580.0 % |
Dec 2023 | 2024-02-27 | $-0.50 | $-0.48 | -4.17 % |
Sep 2023 | 2023-11-07 | $-0.37 | $-0.43 | 14.0 % |
Jun 2023 | 2023-08-01 | $-0.46 | $-0.63 | 27.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-07 | $137.74M | $84.51M | 63.0 % |
Dec 2023 | 2024-02-27 | $32.25M | $28.70M | 12.4 % |
Sep 2023 | 2023-11-07 | $33.97M | $29.58M | 14.8 % |
Jun 2023 | 2023-08-01 | $25.79M | $25.50M | 1.12 % |
Esperion Therapeutics (ESPR) is scheduled to report earnings on August 2, 2024. The last reported earnings were for reported on May 7, 2024 for Q1.
The Actual EPS was $0.34, which beat the estimate of $0.05.
The Actual Revenue was $137.7M, which beat the estimate of $84.5M.
Browse earnings estimates, EPS, and revenue on all stocks.